← FDA DRUG APPROVALS

FDA ANDA · ANDA088391

HYDRALAZINE HYDROCHLORIDE

Sponsor: STRIDES PHARMA INTL

APPLICATION
ANDA088391
TYPE
ANDA
ORIGINAL APPROVAL
1983-09-27
LATEST ACTION
2001-12-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDRALAZINE HYDROCHLORIDEDiscontinued
HYDRALAZINE HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

2001-12-11Labeling · Supplement 11AP
1988-11-04Labeling · Supplement 10AP
1988-07-14Labeling · Supplement 9AP
1986-05-15Manufacturing (CMC) · Supplement 2AP
1983-09-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →